Abstract
A Systematic Review of Cardiovascular Adverse Events in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy and Mitigation Strategies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have